ask="N/A"
ask_size="N/A"
average_daily_volume="48634"
bid="0.9700"
bid_size="200"
book_value="0.8110"
change="+0.0074"
change_from_200_day_moving_average="-0.3098"
change_from_50_day_moving_average="-0.0205"
change_from_52_week_high="-2.4026"
change_From_52_week_low="0.3174"
change_in_percent="+0.4837%"
close="1.5374"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2600"
ebitda="-6.98M"
eps_estimate_current_year="-0.1600"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.4800"
ex_dividend_date="N/A"
float_shares="2843000"
high="1.5602"
high_52_weeks="3.9400"
last_trade_date="1/23/2017"
last_trade_price="1.5374"
last_trade_size="550"
last_trade_time="3:55pm"
low="1.5099"
low_52_weeks="1.2200"
market_capitalization="16.89M"
moving_average_200_day="1.8472"
moving_average_50_day="1.5579"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.0000"
open="1.5300"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-16.7709%"
percent_change_from_50_day_moving_average="-1.3146%"
percent_change_from_52_week_high="-60.9797%"
percent_change_from_52_week_low="+26.0164%"
previous_close="1.5300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.8866"
price_per_sales="4.4258"
revenue="3.80M"
shares_outstanding="10987000"
short_ratio="0.6200"
stock_exchange="NCM"
symbol="CBLI"
volume="19744"
weeks_range_52="1.2200 - 3.9400"
